SciSparc Updates Spin-off of Pharma Portfolio

Ticker: SPRC · Form: 6-K · Filed: Dec 17, 2024 · CIK: 1611746

Scisparc Ltd. 6-K Filing Summary
FieldDetail
CompanyScisparc Ltd. (SPRC)
Form Type6-K
Filed DateDec 17, 2024
Risk Levelmedium
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: spin-off, pharmaceuticals, corporate-action

TL;DR

SciSparc is spinning off its pharma assets to a new public company, aiming to unlock value for both businesses.

AI Summary

On December 16, 2024, SciSparc Ltd. announced updates regarding the spin-off of its advanced clinical-stage pharmaceutical portfolio into a publicly traded company. This strategic move aims to unlock value and allow for focused development of both the core business and the spun-off pharmaceutical assets.

Why It Matters

This spin-off could lead to increased focus and investment in both SciSparc's core operations and its pharmaceutical pipeline, potentially benefiting shareholders through distinct value creation paths.

Risk Assessment

Risk Level: medium — Spin-offs are complex corporate actions that carry execution risks and market reception uncertainties.

Key Players & Entities

  • SciSparc Ltd. (company) — The company filing the report and undergoing the spin-off.
  • December 16, 2024 (date) — Date of the press release announcing the spin-off update.

FAQ

What is the primary purpose of the spin-off announced by SciSparc Ltd.?

The primary purpose is to provide updates on the status of the spin-off of its advanced clinical-stage pharmaceutical portfolio to a publicly traded company.

When was the press release regarding the spin-off update issued?

The press release was issued on December 16, 2024.

What type of company is SciSparc Ltd. filing as?

SciSparc Ltd. is filing as a Foreign Private Issuer.

Which form is SciSparc Ltd. required to file annually, according to the filing?

SciSparc Ltd. is required to file annual reports under cover of Form 20-F.

What was SciSparc Ltd.'s former company name before its name change on January 29, 2021?

SciSparc Ltd.'s former company name was SciSparc Ltd./ADR.

Filing Stats: 317 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-12-17 07:53:49

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SciSparc Ltd. Date: December 17, 2024 By: /s/ Oz Adler Name: Oz Adler Title: Chief Executive Officer and Chief Financial Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.